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A panel of human lung carcinoma lines: Establishment, properties and
common characteristics
G.M. Duchesne*, J.J. Eady, J.H. Peacock & M.F. Pera
Radiotherapy Research Unit, Institute of Cancer Research, Clifton Avenue, Sutton, Surrey SM2 5PX, UK.
Summary A panel of human lung carcinoma lines representing the four main histological types (squamous,
small-cell, large-cell and adeno-carcinoma), and derived from both primary and metastatic sites, has been
established in xenograft and in tissue culture. The highest take rates were achieved when biopsy specimens
were obtained from large tumour masses and cultured lines were most readily established after preliminary
passages as xenografts. The established lines exhibited an overlapping spectrum of biochemical and
morphological characteristics, and showed a tendency to change from one cell type to another, in keeping
with the concept of a common endodermal cell of origin. Radiation resistance appeared to be related to the
large-cell phenotype.
The World Health Organisation (1981) recognises four main
histological types of lung cancer, with differing patterns of
clinical and biological behaviour, and varying prognostic and
therapeutic implications. The most important distinctions are
between small-cell and non-small-cell carcinomas, the former
possessing neuroendocrine properties and relative therapeutic
sensitivity and the latter, features more typical of tissues of
endodermal origin and with greater resistance to treatment.
Since the first reported derivation of a small-cell carcinoma
line in tissue culture (Oboshi et al., 1971), a number of cell
lines have been established, particularly from small-cell
carcinoma, and these have been the subject of extensive
investigation of the biological properties of the different
tumour types. A variety of phenotypic properties have been
studied, including the expression of intermediate filaments,
neural enzymes and hormones, and growth characteristics
and requirements. As yet it has not been possible to attribute
any differences in therapeutic sensitivity directly to these
biological properties but they may relate to the observed
differences in clinical behaviour and therefore warrant
further study.
The panel of lines described here was established in order
to investigate the interrelationships of the different cell types,
to determine growth requirements and therapeutic sensitivity,
and to see whether any relationship to clinical sensitivity
could be derived. A particular effort was made to obtain
material from primary tumours, as the majority of lines
previously studied have been derived from metastatic lesions
(e.g. Carney et al., 1985).
Materials and methods
Specimens
Tumour samples were obtained from patients undergoing
diagnostic or therapeutic procedures, and transferred to the
laboratory in cold tissue culture medium (Ham's F12). Solid
specimens obtained at thoracotomy or removal of sub-
cutaneous metastases were chopped into small fragments and
implanted subcutaneously into male athymic nude mice
(BALB/c). Tumour fragments were also disaggregated into
single-cell suspensions using an enzyme mixture consisting of
pronase (Calbio-Behring), DNase (Sigma) and collagenase
(Boehringer-Mannheim), at 0.5, 0.2 and 0.2mgml- in
serum-free medium respectively, prior to placing in tissue
culture.
Specimens of bone marrow, or pleural or pericardial.
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effusions were centrifuged on a Ficoll gradient (1.077gml-1)
in order to separate tumour cells from erythrocytes, prior to
plating in culture. Specimens were also obtained from fibre-
optic bronchoscopy but generally contained very few cells.
The larger specimens from rigid bronchoscopy were
implanted into nude mice when sufficient material was
available, but otherwise all bronchoscopy samples were
partially disaggregated with collagenase and placed in
culture. The cells were placed in culture and routinely
maintained in Ham's F12 medium supplemented with 15%
donor calf serum (Flow Laboratories) and gassed with a
humidified atmosphere of 5% C02, 5% oxygen and 90%
nitrogen. Cultures of small-cell carcinomas were also set up
in parallel in Ham's F12 supplemented with HITES
(hydrocortisone, insulin, transferrin, estradiol and selenium,
Simms et al., 1980). 25cm2 culture flasks (Nunc) were
employed until cell lines were established and then cultures
were routinely maintained in 80cm2 flasks. No primary
culture of non-small-cell tumours was successful and
cultured lines were subsequently derived from established
xenograft lines as described above. The use of heavily
irradiated feeder cells was not required for the maintenance
of the cultured lines, with the exception of the
adenocarcinoma line HX144, which required the presence of
3T3 mouse fibroblasts when plated at low density.
Cells were initially plated at high density, - 2 x 106 viable
cells per 5ml, viability being assessed by refractility under
phase contrast microscopy. They were maintained at high
density until the line was established and progressive growth
observed. Cultures which showed no growth after 4 to 6
months were discarded. Established cell lines were
introduced into nude mice by s.c. flank injection of cell
pellets containing about 2 x 106 cells in 0.2ml medium to
confirm tumorigenicity and to allow histological
examination. Absence of mycoplasma contamination was
confirmed using fluorescent Hoechst 33258 dye (Chen, 1977).
Immunohistology
Immunostaining was performed on alcohol-fixed, paraffin-
embedded tissue sections of xenograft tumours after they
had been dewaxed with xylene and rehydrated, or on
acetone:methanol fixed preparations of cultured cell lines. A
standard double-antibody technique was used to determine
the presence of intermediate filaments and creatine kinase
BB isoenzyme in the specimens, using either immuno-
fluorescence or the indirect alkaline phosphatase or
peroxidase reactions for immunohistochemistry. Appropriate
positive controls, tissues known to contain the antigen under
study, were run in parallel with the test samples, and sections
stained only with second-layer antibodies were used as
negative controls. The antikeratin antibody CAM 5.2
(described by Makin et al., 1984) was used to determine the
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presence of low molecular weight cytokeratins. Neuro-
filament and vimentin antibodies were obtained from
Eurodiagnostics, and creatine kinase BB isoenzyme
antiserum from Chemicon Inc. Conjugated second layer
antibodies were obtained from Zymed and Miles Inc.
Electron microscopy
Specimens for electron microscopy were fixed in 2%
glutaraldehyde in 0.05 M phosphate buffer, with the molarity
adjusted to 350mOsM by the addition of sucrose. They were
post-fixed in 1% osmium tetroxide, dehydrated in ethanol
and embedded in Epon/Araldite prior to sectioning for
ultrastructural examination.
Assay of L-dopa decarboxylase (DDC)
DDC was assayed using a modification of the technique
described by Beaven et al. (1978), measuring the release of
14CO2 from 14C-labelled 3,4-dihydroxyphenylalanine
(Amersham International) by the enzyme in cell sonicates.
Essentially, non-enzymatic decarboxylation of the substrate
was inhibited using 1 mM 2-mercaptoethanol (Sigma) and
0.1 mM versene (BDH), and the assay was conducted at
pH 7.6 in 0.1 M Tris buffer. The enzyme levels were
expressed as nanomols of 14CO2 released per hour per mg of
soluble protein; protein was measured using the Bradford
technique, (Bradford, 1976), measuring change in optical
density occurring with protein-dye binding.
Assay of neuron-specific enolase (NSE)
Assay of this enzyme was performed using a modification of
the method of Cooper et al. (1985) using a radioimmuno-
assay developed by Pharmacia, Sweden for the measurement
of enzyme levels in serum. Soluble protein fractions from the
tumour lines were prepared by sonication and ultra-
centrifugation at 4°C and 100,000g for 40min, and aliquots
of the supernatant were assayed for NSE and protein
concentration. Standard and unknown aliquots were
incubated with 125-labelled NSE and rabbit anti-NSE
antiserum and the bound NSE was then precipitated with a
sheep antirabbit IgG-sepharose complex, centrifuged at
1,500g for 10min and the activity in the residual pellet
counted. The unknown levels were determined from the
standard calibration curve, and the NSE levels expressed as
ng mg 1 soluble protein.
Assay of immunoreactive bombesin (IRB)
A double antibody radioimmunoassay technique (Immuno-
nuclear Corporation) was used to determine the levels of
immunoreactive bombesin in the tumour lines. The soluble
protein fraction obtained from freeze-dried preparations of
the tumour cell lines was resuspended in distilled water and
aliquots were incubated with 1251-bombesin and rabbit anti-
bombesin antiserum. The activity in the precipitated bound
antibody complex was counted and the unknown bombesin
concentrations derived from a standard calibration curve.
The results were expressed as pmol bombesinmg-' of
soluble protein.
Chromosome analysis
Cell suspensions from tumours or cultured cell lines were
incubated in fresh culture medium for 24h, and then with
colcemid (Gibco Laboratories) at a final concentration of
0.05 to 0.1 ugml-1 for 4h. The cells were suspended in
hypotonic potassium chloride solution (0.075M) for 15min
and fixed using 3:1 methanol and glacial acetic acid, spread
onto cold glass slides and stained with Giemsa for
examination.
Radiation sensitivity
The sensitivities of the tumour lines to acute irradiation were
determined using the soft agar clonogenic assay described by
Courtenay and Mills (1978). Single cell suspensions were
irradiated at room temperature using a 60Co source at a
dose rate of 1.5Gymin-1, and then cultured in soft agar
until colony formation was observed. Survival after
irradiation was calculated relative to control plating
efficiency, and the responses were expressed in terms of the
multitarget and linear quadratic models of survival (derived
as described by Millar et al., 1978), and the surviving
fraction at 2Gy, SF2 (Deacon et al., 1984). Full details are
described elsewhere (Duchesne et al., 1986).
Results
Establishment ofxenografts and cultured cell lines
Forty-one tissue specimens were obtained from 38 patients;
the types of specimen are detailed in Table I together with
the positive take rates either in xenograft or in culture for
the different histological types. Eleven of the 15 marrow
specimens were negative for malignant cells on histological
examination; one of these showed initial growth in culture of
an undetermined cell type, which failed after 3 months.
Seven fibre-optic bronchoscopy specimens were obtained, of
which 2 did not contain malignant cells, and no successful
culture or xenograft was established from the remaining 5
specimens. Tissue obtained at thoracotomy or from other
large biopsies or malignant effusions resulted in a high take
rate in xenografts (for solid specimens) or culture (effusions)
for bronchogenic carcinoma but 2 carcinoid tumours, one
oesphageal squamous carcinoma and one lymph node
containing Hodgkin's disease failed to grow.
Of the 23 lung carcinoma specimens which contained
cytologically detectable numbers of tumour cells, 13 were
successfully established as tumour lines. Of these, ten
(obtained from solid tumour specimens), were primarily
established as xenograft lines, although no cultured cell line
was derived directly from these tumours. Subsequently
Table I Success rates of establishing lines according to tumour origin and type
Origin Number Lung SC Sq Ad LC SC/Sq Total
+ _a
Thoracotomy 8 7 0 2/2 2/2 2/2 1/1 7/7
Solid specimens 6 3 0 1/2 1/1 2/3
Marrow 15 4 1 1 1/4 - 1/4
Effusions 2 2 0 2/2 - 2/2
Bronchoscopy
Rigid 3 2 1 1/1 0/1 - 1/2
Flexible 7 5 2 0/4 0/1 0/5
41l 23 14 6/13 2/3 3/4 1/2 1/1 13/23
aMalignant cells present (+) or absent (-) on microscopic examination. bFour
specimens were found to be tumour other than lung carcinoma: 2 carcinoid
tumours, 1 oesophageal squamous carcinoma, 1 Hodgkin's disease. SC=small-
cell, Sq=squamous, Ad=adenocarcinoma and LC=large-cell carcinoma.HUMAN LUNG CARCINOMA PANEL 289
attention was focussed on deriving cell lines from
xenografted tumours, and five such lines were successfully
established in culture (HX144, HX147, HX148, HX149 and
HX168 - see Table II). Three primary cultures were
established from effusions or bone marrow specimens
(HC12, HC38 and HC39) and were subsequently
demonstrated to be tumorigenic in nude mice. The
histological appearances of the xenograft tumours and
tumours derived from inoculation of cell lines into nude mice
were similar to those of the patient specimens from which
they were derived, (e.g. Figure la, b - patient and xenograft
tumours of HX147).
Table II Site, histology, and history of established tumour lines
Tissue of Biopsy Previous Xenograft (XG)
Line Histology origin technique treatment or cell line (CL)
HX
144 Adenocarcinoma 1° tumour Thoracotomy None XG-+CLa
145 Squamous 10 tumour Thoracotomy None XG
146P Squamous 10 tumour Thoracotomy CT/RT XG
146N Sq/small-cell Thoracic node Thoracotomy CT/RT XG
147 Large-cell S/C metastasis Excision RT XG--CL
148 Adenocarcinoma S/C metastasis Excision None XG-+CL (148M)b
149 Small-cell (C) 1 tumour Thoracotomy CT XG-+CL (149M)C
150 Small-cell (C) 1° tumour Bronchoscopy CT XG
154 Adenocarcinoma Thoracic node Thoracotomy None XG
168 Small-cell (C) 1° tumour Thoracotomy None XG--CL (HC41)
HC
12 Small-cell (C) Effusion Aspiration CT/RT CL--XG
38 Small-cell (C) Effusion Aspiration None CL
39 Small-cell (C) Marrow Aspiration None CL-+XG
aWith heavily-irradiated 3T3 feeder cells; bA mixed large-cell adenocarcinoma line HX148M was
derived between passages 15-20 of HX148; cHX149M, a variant small-cell carcinoma, arose from
the second xenograft passage of HX149 (see text); cClassical small-cell carcinoma. CT and RT:
chemotherapy and radiotherapy.
Figure 1 (a) Donor tumour of HX147, a large-cell anaplastic carcinoma with cellular pleomorphism and a fibrous stroma, similar
to; (b) the fourth xenograft passage of the tumour line (both H&E); (c) Seventh xenograft passage of HX148 demonstrating mucin
production as a feature of adenocarcinoma (Alcian Blue and Periodic acid-Schiff); (d) HX148 in tissue culture showing both
small- and large-cell components.290 G.M. DUCHESNE et al.
Two sublines were derived from this panel of tumours
through changes in the growth or morphological
characteristics of an established xenograft or cell line.
HX149, a classical small-cell carcinoma, grew slowly in the
mouse host with a doubling time of 18.5 days, until a
sudden acceleration of growth (with a tumour doubling time
of 5.2 days) during the fourth xenograft passage was noted
in one mouse, together with extensive subcutaneous spread.
The histology of this tumour (designated HXI49M) was
similar to that of the parent line, although the cells were
slightly larger with more prominent nucleoli (Figure 2a, b),
and the line grew in tissue culture as an attached monolayer
instead of the floating aggregates typical of the parent line
(Figure 2c, d). Ultrastructural examination of HX149 showed
the presence of dense-core granules (Figure 3a) but no
evidence of features suggestive of epithelial differentiation,
whereas HX149M contained desmosomes and microvilli in
addition to occasional dense-core granules (Figure 3b).
Stored tissue from the second xenograft passage was
reintroduced into nude mice but did not show the same
acceleration of growth subsequently. The HX149M subline
has been classed as a morphological variant small-cell
carcinoma (Gazdar et al., 1985), supported by its
biochemical profile (see Table III); its human origin was
confirmed by chromosomal analysis.
The second subline arose from the adenocarcinoma
HX148 which was established in tissue culture from the fifth
xenograft passage of the tumour. In early passages in tissue
culture and xenograft (Figure 1c) small cells suggestive of
adenocarcinoma in appearance, with a diploid modal
chromosomal number, comprised the whole population of
the line but between the 15th and 20th passage a population
of large cells emerged (Figure Id) and chromosomal analysis
showed that 12% of the population now had an
approximately tetraploid chromosome complement. This
mixed adenocarcinoma/large-cell line was designated
HXI48M, and the two cell types are currently being cloned.
Some of the morphological and biochemical characteristics
remain the same but others have altered between the cell
types: for example, the expression of cytokeratins was not
seen in all cells of the large-cell population, whereas
consistent staining was observed throughout the smaller
cells.
Chromosomal analysis
The human origin of all lines was confirmed by examination
of metaphase spreads. The majority of lines had a single
aneuploid peak, with their modal chromosome numbers
ranging from 46 to 59. HX148 in tissue culture developed a
bimodal distribution with modal numbers of 46 and 84,
which was associated with the emergence of a large-cell
population. The cultured line HX149 had a bimodal
distribution from the outset, with modal numbers of 51 and
94, whereas HX149M had a single modal chromosome
number of 59.
Expression of intermediate filaments
All the lines examined expressed low molecular-weight
cytokeratins; although present in all the small-cell tumours,
staining was consistently more intense in the non-small-cell
lines. A difference was noted between the adenocarcinoma
and large-cell types of the mixed line HX148M, as some of
the larger cells of the mixed population showed less intense
staining for keratins or neurofilaments than was observed in
the cells of the pure adenocarcinoma line. Neurofilament
expression was observed in a minority of cells in all the
small-cell lines including the variant line, and faint staining
was also seen in the two adenocarcinomas examined but not
in the large-cell or squamous carcinomas. The variant small-
cell carcinoma HX149M exhibited the same pattern of
staining as its parent classical line HX149. Vimentin was
expressed in varying degrees in the cell lines, a phenotypic
property frequently found in cultured cells.
Figure 2 HX149 and the subline HX149M: (a) and (b) in the third and fifth xenograft passages respectively (H&E); (c) HX149
growing in tissue culture as floating cell aggregates; (d) HX149M growing in tissue culture as an adherent monolayer.HUMAN LUNG CARCINOMA PANEL 291
Figure 3 Electron micrographs of HX149 (a) and HX149M (b). x: dense-core granules contained in a cell process. y: microvillus
formation suggestive of glandular differentiation. z: attempted desmosome formation. Only the occasional dense-core granule is
seen.
Neural enzymes andpeptides
Six lines established in tissue culture have been characterised
in detail with respect to L-dopa decarboxylase, neuron-
specific enolase, immunoreactive bombesin and creatine
kinase BB isoenzyme (CK-BB) expression, and now form the
basis of a panel of lines which is being further investigated
with respect to therapeutic response. CK-BB was not
measured directly but was examined using immuno-
fluorescence. The classical small-cell carcinomas, the variant
line HX149M, and the large-cell carcinoma HX147 all
stained for the presence of this enzyme, and staining was
particularly intense in HX149. In contrast, no staining was
observed in either the small- or large-cell component of
HX148M. Assay of the other three neural markers (Table
III) showed high levels of all these markers in the classical
small-cell carcinomas, but also occasional production at low
levels by the other lines examined.
Radiation sensitivity
The radiation survival parameters are presented in Table IV.
No conclusive differences in Do (multitarget model) were
found between the tumour types. Examination of the
parameters a and SF2, thought to be more discriminating in
intrinsic radiosensitivity (Fertil & Malaise, 1981), showed
that the classical small-cell carcinomas and the adeno-
carcinomas were significantly more radiosensitive than those
lines containing a large-cell component (P<0.01 and
P<0.05 respectively). Additionally the small-cell carcinoma
cell line HC12 which had been heavily treated with both
irradiation and drugs in the patient, was significantly less
radiosensitive than those small-cell lines which had not been
irradiated in situ (P<0.05). A decreased radiosensitivity was
observed in the two sublines HX148M and HX149M which
showed a change towards large-cell morphology, compared
with the parent lines.
Table III Radioassay of dopa decarboxylase, neuron-specific enolase and
immunoreactive bombesin in six lung cancer cell lines
DDC NSE IRB
Tumour Type (nmolmg-'h- )a (ngmg-1)a (pgmg-)a
HX147 Large-cell Nil 63.3+6.9 0.4+0.07
HX148 AdenoCa 2.8+0.2 52.2+3.4 Nil
HXl49M Small-cell (V) Nil 8+0.46 0.6+0.09
HC12 Small-cell (C) 38.4+4.6 764+102 6.6+0.68
HX149 Small-cell (C) 82.2+4.1 4033 + 162 25.8+3.85
HX168 Small-cell (C) 94.3+3.8 1026+ 133 14.3+1.37
amg =mg soluble protein. DDC=1-dopa decarboxylase. NSE = neuron-
specific enolase. IRB =immunoreactive bombesin. C= classical. V=variant.
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Table IV Comparison of radiation sensitivities of different histological
types
Cell type Do a SF2
Small-cell (no RT) 1.21 +0.24 0.610+0.09 0.29+0.06
Small-cell (RT) 1.23 0.412 0.45
Small-cell (variant) 1.78 0.206 0.66
Adenocarcinoma 1.81 +0.08 0.380+0.06 0.43+0.13
Adeno/large-cell 1.39 0.137 0.81
Large-cell 1.48 0.228 0.64
RT: tumour treated with irradiation in the patient.
Discussion
The experience described here has allowed us to develop an
efficient procedure with which to establish tumour lines,
both as xenografts and in culture, from human lung cancer
for further laboratory study. An observation of practical
importance is that lines have been most readily established
from patient specimens in which large numbers of malignant
cells were identified on light microscopy. Our experience
with bronchoscopy specimens has shown that they rarely
yield sufficient material to allow establishment of a line, and
our attempts from fibreoptic bronchoscopy specimens were
uniformly unsuccessful. Also of practical benefit was the ease
of establishing of cell lines in tissue culture after the tumour
line has first been passaged through a murine host, as
suggested previously by Gazdar et al. (1981a).
The established cell lines retained the characteristics of the
xenografts from which they were derived, which in turn
resembled the patient tumours as far as could be determined
(for example, in histological appearance and immunohisto-
chemicBl staining, cell size and chromosomal complement).
In addition, the radiation sensitivities of cells whether from
xenografts or cultured cell lines derived from the same
tumour did not differ significantly (Duchesne, unpublished
observations), supporting the usefulness of this approach in
establishing representative cell lines.
The characterisation of the lines with respect to expression
of neural and epithelial markers confirms the current view
that all types of lung carcinoma arise from an epithelial
origin. Previous observations of the expression of neuro-
endocrine enzymes and peptides by small-cell carcinomas
(e.g. Gazdar et al., 1981b; Moody et al., 1981; Sheppard et
al., 1984) demonstrated a clear distinction from the non-
small-cell tumours, and suggested that these tumours might
be neuroectodermal in origin. Later reports (e.g. Carney
et al., 1985), supported by the present findings, have
demonstrated the expression of such properties by some non-
small-cell carinomas, although generally to a lesser extent.
This is in keeping with the concept that lung cancer cells
may express markers of more than one differentiation
pathway, and emphasises the close relationships of the cell
types.
The pattern of intermediate filament expression in the
different histological types also reflects the capacity of lung
carcinoma cells to express markers of differing cell lineages,
although neoplasms generally retain the intermediate
filament structure of their tissue of origin (Altmannsberger et
al., 1981). All the lines studied here expressed cytokeratins,
in keeping with previous reports (e.g. Bernal et al., 1983;
Blobel et al., 1984). Staining for neurofilament was observed
in all the small-cell carcinomas, both classical and variant,
and adenocarcinomas, but not in the squamous or large-cell
lines. The expression of neurofilaments in small-cell
carcinomas is still debated (e.g. Bergh et al., 1984; Van
Muijen et al., 1984), but the present observations would be
consistent with the explanation offered by Clark et al.
(1985), that neurofilament expression is facultative, and
occurs only in terminally differentiated cells.
The interrelationships of the cell types are also revealed by
the observed alterations in morphological and biochemical
characteristics of the lines through successive passages,
illustrated by the changing characteristics of HX148/148M
and HX149/149M. The emergence of a large-cell component
in the cell line of HX148 was associated with the appearance
of a bimodal chromosomal distribution (the higher modal
number being distinct from that of any of the other tumour
lines) and a change in the morphology of some of the cells
and in radiation sensitivity. It was not possible to determine
whether the large-cell component had been present initially,
but further studies are underway to clone the two cell
populations, and investigate the change in characteristics
further. The change in growth pattern and cell type between
HX149 and HX149M occurred in xenograft passage, and
has not been observed in the cultured line. This may indicate
modification of the tumour cell type by the host
environment as previously suggested by Carney et al. (1983),
or the existence of a small initial subpopulation of cells
particularly suited to growth in this host which overgrew the
original cell type. The observation is of clinical relevance as
it may be analogous to the changes in morphology seen in
small-cell tumours after therapy, and provides a reason for
possible therapeutic resistance in what is usually considered a
sensitive tumour.
No consistent differences in biological behaviour or
tumour markers were found between tumours from primary
or metastatic sites, although it is recognised that the number
of lines is small, and that any such differences might
therefore not be detected. Consistent differences in radiation
sensitivity have been found, however, between the different
histological types, with the lines with a large-cell component
exhibiting intrinsic radioresistance, and the other histological
types being relatively radiosensitive. There is a suggestion
that those small-cell lines which had not been previously
irradiated (e.g. HX168, HC38 and HC39) were more
radiosensitive than those which had been heavily pretreated,
such as HC12 which showed therapeutic resistance to both
drugs and radiation in the patient. Interestingly HC12, which
is morphologically a classical small-cell carcinoma, exhibits a
biochemical profile and radiation sensitivity intermediate
between that of the other classical lines and the large-cell
lines. It is tempting to speculate that the spectrum of
radiosensitivity observed relates directly to the degree of
expression of the neuroendocrine phenotype, and that the
resistance to radiation observed clinically in some tumours
may result from the presence or emergence of a large-cell,
non-endocrine component.
The results presented here confirm the overlap of neuro-
endocrine and endodermal features in the small-cell and non-
small-cell tumours and are in keeping with the current
concept that all the tumours arise from a common cell of
origin. It is suggested that there is no rigid distinction
between the different tumour types but rather that the cells
may undergo phenotypic alterations from one type to
another. Radiation resistance appears to be related to the
large-cell phenotype, and a spectrum of response is seen
which parallels the spectrum of neuroendocrine expression.
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indebted to Dr J. Millar, Dr V. Macaulay and Dr J. Delic for their
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